2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases

Details for Australian Patent Application No. 2004259737 (hide)

Owner Amgen Inc.

Inventors Nunes, Joseph J.; Novak, Perry M.; Buchanan, John L.; Martin, Matthew W.; McGowan, David C.; Elbaum, Daniel

Agent Shelston IP

Pub. Number AU-A-2004259737

PCT Pub. Number WO2005/009978

Priority 10/891,636 13.07.04 US; 60/490,220 24.07.03 US

Filing date 15 July 2004

Wipo publication date 3 February 2005

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009978 Priority application(s): WO2005/009978

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259738-PPAR active compounds

2004259736-Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands